Detalhe da pesquisa
1.
A systematic review on the cost-effectiveness assessment of tisagenlecleucel for refractory or relapsing B-cell acute lymphoblastic leukemia (R/R B-ALL) treatment in children and young adults.
Cytotherapy
; 25(9): 930-938, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341664
2.
Hallmarks of aging and immunosenescence: Connecting the dots.
Cytokine Growth Factor Rev
; 59: 9-21, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33551332